Unlocking the potential of
genomic medicine

2018 News Releases

Date Title
Toggle Summary05/26/2010
Toggle Summary05/17/2010
Medgenics (LSE: MEDG, MEDU), the company that is developing a novel approach to the manufacture and delivery of therapeutic proteins continuously in patients using their own tissue, is proud to announce today the appointment of Nomura Code Securities as joint-broker to the Company with SVS
Toggle Summary04/27/2010
Toggle Summary04/15/2010
Toggle Summary03/30/2010
Toggle Summary10/23/2009